Mast Cells

  • Derived from bone marrow (CD34+ cells), often in perivascular spaces
  • Contain proinflammatory and vasoactive mediators; play important role in wound healing, allergy, anaphylaxis, urticaria, and angioedema (Tables 1-14, 1-15)
  • Mast cell proliferation dependent on ligand for c-kit receptor (syn: steel factor, mast cell growth factor, stem cell factor); c-kit encodes a tyrosine kinase receptor and an activating mutation in c-kit proto-oncogene can be associated with childhood and adult-onset mastocytosis
  • All mast cells express high affinity receptors for IgE (FcεRI) on their surface; cross-linking of receptor-bound IgE results in release of mast cell granule contents (preformed or newly formed)
  • Of note, patients with chronic urticaria may have circulating antibodies to FcεRI on mast cell surface
   
 
Table 1-14 Mast Cell Mediators
 Mediator Function
Preformed Mediators
 
Histamine
Vasodilatation, smooth muscle contraction, increased vasopermeability
 
Heparin (Proteoglycan)
 
Anticoagulant, anti-complement activity, regulate activity of other mediators
 
Tryptase
Serine protease
 
Chymase
 
Serine protease
 
Carboxypeptidase-A
Protease
 
Cathepsin G
 
Protease
Newly-Formed Mediators
 
Prostaglandin D2 (PGD2)
 
Smooth muscle contraction
 
Leukotrienes (LTC4, LTD4, LTE4)
Lipid mediators
 
Platelet-activating factor (PAF)
 
Vasconstriction, platelet aggregation, smooth muscle contraction, chemotaxis for eosinophils and neutrophils
 Cytokines
 
Either preformed or newly-formed: TNFα, IL-3, IL-4, IL-5, IL-6, IL-8, IL-13
    
 
     
  Of note, PGE2 has inhibitory effect on mast cell degranulation  
     
 
   


   
 
Table 1-15 Triggers for Mast Cell Degranulation
Mast Cell Degranulating Stimuli
 Specific antigens (which result in bridging of FcεRI)
 Anti-FcεRI autoantibodies
 IL-3
 Stem cell factor (SCF)
 C3a, C4a, C5a (anaphylatoxin)
 Drugs: NSAIDs, opiates, aspirin, vancomycin, polymyxin B, curare
 Radiocontrast media
 Some neuropeptides (i.e., substance P)